Metabolic Consequences of Cross-sex Hormonal Treatment
NCT04508231 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 98
Last updated 2020-08-11
Summary
Retrospective study in a single academic regional transgender referral center. Analyse VAT, body composition and metabolic parameters in non-obese transgender subjects one year after starting gender-affirming hormone therapy and in controls
Conditions
- Gender Dysphoria
Interventions
- OTHER
-
Gender-affirming hormone therapy
Gender-affirming hormone therapy according to the recommendations of the Endocrine Society
Sponsors & Collaborators
-
Central Hospital, Nancy, France
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-24
- Primary Completion
- 2021-12-01
- Completion
- 2021-12-01
Countries
- France
Study Locations
More Related Trials
-
Evaluation of the Effectiveness of Hormonal Treatment in Adolescents Suffering from Gender Dysphoria
NCT06351501 ·Status: RECRUITING ·Phase: PHASE3
-
Effects of Gender-Affirming Hormone Therapy Among Transgender Women
NCT04128488 ·Status: COMPLETED
-
Feminizing Treatment in Transgender Women and Non-binary Persons
NCT05169762 ·Status: RECRUITING
-
Decrease of Libido of Post-Operative Male-Female Transsexuals and a Healthy Female Control Group
NCT00135148 ·Status: COMPLETED
-
Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors
NCT04551144 ·Status: TERMINATED
-
Influences of Long Term Hormone Therapy on Physical Fitness and Vascular Function in Transgender Women
NCT06116201 ·Status: COMPLETED ·Phase: NA
-
Metabolic and Physiologic Responses to Hormone Therapy in Transgender and Gender Diverse People
NCT06083766 ·Status: RECRUITING
-
Effect of Estrogen Treatment on Drug Metabolism and Transport
NCT05469204 ·Status: COMPLETED ·Phase: PHASE4
-
Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content
NCT06291675 ·Status: RECRUITING
-
Pain Outcomes Associated With Exogenous Hormone Therapy in Adults
NCT06939257 ·Status: RECRUITING
-
Transgender Estradiol Affirming Therapy
NCT05010707 ·Status: COMPLETED ·Phase: PHASE2
-
Reciprocal Influence of Sex Steroid Environment and Adipocyte Function in Men
NCT00740194 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Perception of Hormonal Replacement Therapy Among Patients Aged 11 to 17 Years
NCT07315932 ·Status: RECRUITING
-
Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway
NCT07187947 ·Status: RECRUITING
-
Reduction of Triglycerides in Women on Hormone Replacement Therapy
NCT00023543 ·Status: COMPLETED ·Phase: PHASE2
-
Progesterone in Gender Affirming Hormone Therapy Study
NCT06807580 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women
NCT04283656 ·Status: COMPLETED ·Phase: PHASE1
-
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
NCT06969326 ·Status: RECRUITING ·Phase: PHASE3
-
Sex Hormone Therapy and Mucosal Tissues
NCT02983110 ·Status: COMPLETED
-
i2TransHealth: Interdisciplinary, Internet-based Trans Health Care
NCT04290286 ·Status: COMPLETED ·Phase: NA
-
The Anabolic Effects of Estrogen on Skeletal Muscles
NCT03020953 ·Status: COMPLETED ·Phase: NA
-
TRANSDERMAL HRT RELIEVING POSTMENOPAUSAL SYMPTOMS
NCT02033512 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Testosterone Treatment on Clitoral Arteries' Hemodynamic Parameters.
NCT04336891 ·Status: COMPLETED
-
Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido
NCT00331214 ·Status: COMPLETED ·Phase: PHASE3
-
Estrogen Exposure and Atherosclerosis in Postmenopausal Women
NCT02951949 ·Status: COMPLETED